Bitcoin ZK Rollup project Citrea launches token CTR
Foresight News reports, according to The Block, the Bitcoin ZK Rollup project Citrea has launched the CTR token. The total supply of CTR is capped at 10 billion tokens, with 60% allocated to the community. This includes 12% distributed as initial shares during the genesis airdrop, 25.16% into the treasury managed by xCTR, and 22.83% designated for ecosystem development. The remaining 40% consists of 19.35% allocated to investors and 20.66% to early contributors. These tokens will be locked and released gradually after 4 years.
Citrea also introduces a dual treasury system, where the Citrea governance treasury is directly controlled by xCTR holders, who will vote on liquidity incentives, council and infrastructure providers, and payments. The independent Citrea Foundation treasury will be responsible for research and development, ecosystem funding, operations, and strategic initiatives.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
"Gold bracelets out of stock"! Shuibei gold, foreign tourists group-buying shopping
Analyst Gu Jingci: Follow the trend and adapt flexibly
XRP Ledger adds account control feature, enabling enterprises to manage assets offline.
BUZZ - Goldman Sachs says the price cap on cancer drugs has limited impact on Indian hospitals
October 9 – Goldman Sachs pointed out that India's implementation of a 30% profit margin cap on non-scheduled anticancer drugs (link) will have limited impact on hospitals. The report states that, based on preliminary discussions with hospital chain groups, such drugs account for less than 5% of hospital revenue and 2% to 2.5% of operating profit. The report adds that hospitals can offset the losses by slightly adjusting service charges, such as administration fees. According to a government notice, an expert committee will finalize the list of drugs to be brought under regulation. Driven by the anticipated price cap, the share prices of Max Healthcare MAXE.NS, Apollo Hospitals APLH.NS, and Fortis Healthcare FOHE.NS rose by 1.6% to 2.5%. Previously, since September 30, these stocks had collectively declined by 11% to 11.5%. Year-to-date, FOHE and MAXE are down 11.7% and 14.8%, respectively, while APLH has risen by 11%. (To assist non-English speakers, Reuters provides automated translations of its reports into several other languages. Due to potential errors or missing context in automated translations, Reuters does not guarantee the accuracy of automatic translation texts and offers them solely for readers’ convenience. Reuters accepts no responsibility for any damage or loss caused by using these automated translation features.)
Crypto prices
More
